DOI: http://dx.doi.org/10.18203/2349-3933.ijam20204521

Descriptive study of clinical profile and outcome in patients of acute on chronic liver failure, at a tertiary care center in Northern India

Rakesh Kumar, Vandana Rana, Varghese Koshy, Vandana Gangadharan, George Koshy

Abstract


Background: Acute-on-chronic liver failure (ACLF) is a recently described syndrome that is characterized by abrupt deterioration in patients with chronic liver disease (CLD) and has high short-term mortality. The aim of this study was to describe the clinical profile, causes and outcomes of ACLF at a tertiary care centre in Northern India.

Methods: In this descriptive study of 50 consecutive patients, were included, between August 2015 to January 2018, who were admitted and diagnosed as ACLF as defined by APASL. Causes of acute precipitating event and CLD and outcomes were assessed.

Occurrence and severity of organ failure was also assessed.

Results: 48 (96 %) were males and 2 (4%) were females with male to female ratio was 24:1. The mean age of male and female subjects was similar, 40.7±9.9 years and 39.2±9.4 years respectively. The most common cause of CLD was alcohol in 50% cases and next most common cause was hepato-tropic viruses HBV infection in 20%, HCV in 6% cases and there was unknown cause in 12 % cases. The most common precipitating factor of acute decompensation was alcohol in 50% cases, hepatotropic viruses in 30% cases. Excluded sepsis and GI bleed as precipitating events. The combined mortality at the end of 1-month and 3-months, in our study was 60%. CLIF-SOFA score was found to be the most reliable scoring system to discriminate between survivors and non survivors. 

Conclusions: Alcohol was the commonest precipitating cause of ACLF. Organ failures (OFs) are independently predictive of mortality.


Keywords


ACLF, CLD, Cirrhosis, UGI Bleed, HBV infection, HCV Infection

Full Text:

PDF

References


Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G et al. Acute-on chronic liver failure. J Hepatol. 2012;57(6):1336-48.

Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3(1):269-82.

Jala NR, Yurdaydin C, Bajaj JS, Acharya SK, Arroyo V, Lin H-C et al. Toward an Improved Definition of Acute-on-Chronic Liver Failure. Gastroenterol. 2014;147(1):4-10.

Shalimar, Saraswat V, Singh SP, Duseja A, Shukla A, Eapen CE et al. Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience: ACLF-Indian experience. J Gastroenterol Hepatol. 2016;31(10):1742-9.

Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiol. 1997;202(1):1-16.

Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-9.

Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatol. 2000;31(4):864-71.

Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J et al. Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis. Gastroenterology. 2013;144(7):1426-37.

Chu CM, Liaw YF. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol. 2005;43(3):411-7.

Buchel E, Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol. 2002;97(12):3160-5.

Acharya SK, Sharma PK, Singh R, Mohanty SK, Madan K, Jha JK et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46(3):387-94.

Krishna YR, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R et al. Clinical features and predictos of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29(3):392-8.

Kumar M, Sharma BC, Sarin SK. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol. 2008;23(6):883-7.

Monga R, Garg S, Tyagi P, Kumar N. Superimposed acute hepatitis E infection in patients with chronic liver disease. Indian J Gastroenterol Off J Indian Soc Gastroenterol. 2004;23(2):50-2.

Ramachandran J, Eapen C, Kang G, Abraham P, Hubert DD, Kurian G et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol. 2004;19(2):134-8.

Hamid S. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology. 2002;36(2):474-8.

Shrestha MP, Scott RM, Joshi DM, Mammen MP, Thapa GB, Thapa N et al. Safety and Efficacy of a Recombinant Hepatitis E Vaccine. N Engl J Med. 2007;356(9):895-903.

Das K, Jain A, Gupta S, Kapoor S, Gupta RK, Chakravorty A et al. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol. 2000;16(6):507-10.

Hussain Z, Das BC, Husain SA, Murthy NS, Kar P. Increasing trend of acute hepatitis A in north India: Need for identification of high-risk population for vaccination. J Gastroenterol Hepatol. 2006;21(4):689-93.

Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatol. 2011;53(3):774-80.

Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N. Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol. 2006;37(3):206-12.

Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled study. Liver Transpl. 2004;10(9):1109-19.

Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E et al. Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis. J Hepatol. 2005;42(2):195-201.

Heemann U. Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatol. 2002;36(4):949-58.

Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H et al. Molecular Adsorbent Recycling System (MARS): Clinical Results of a New Membrane‐Based Blood Purification System for Bioartificial Liver Support. Artif Organs. 1999;23(4):319-30.

Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol. 2006;21(10):1519-24.

Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC et al. Granulocyte Colony-Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients with Acute-on-Chronic Liver Failure. Gastroenterol. 2012;142(3):505-12.

Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat. 2009;16(7):464-70.

Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol. 2006;21(10):1519-24.